Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...

Though the baseline illness severity was uneven, with more severe patients in the itolizumab arm, the medication showed great ...

Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...

Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...

There are several treatments for ulcerative colitis (UC), including JAK inhibitors. JAK inhibitors are a type of medication to manage moderate to severe UC. Doctors typically prescribe them if ...

Resilience has characterized many people who have dealt with chronic health challenges, and it would be hard to find someone ...

Unfortunately, ulcerative colitis can occur in anyone, including pregnant women. But that does not mean you do not plan for a family. With proper management and treatment, women can experience a ...

Ulcerative colitis (UC) symptoms may include abdominal pain, cramping, and diarrhea. People can experience periods of remission followed by flare-ups, which can lead to treatment changes.

Ulcerative colitis medications help control the symptoms of ulcerative colitis (UC) and prevent flare-ups or relapses. UC is a chronic inflammatory bowel disease. It's an autoimmune condition ...

Equillium, Inc. (NASDAQ:EQ), a biotechnology company with a market capitalization of $25.15 million and current stock price of $0.71, announced today the positive outcomes of their Phase 2 clinical ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...